Deals channel feed – Endpoints News

Deals channel feed

J&J looks at potential bid for Intra-Cellular — report

3 months ago

Biogen offers to buy out struggling neuro partner Sage Therapeutics

4 months ago

City Therapeutics, Bausch + Lomb partner on preclinical RNAi eye drug

4 months ago

Four biotechs emerge with $800M and in-licensed assets on Friday

4 months ago

Another biotech scoops up asset from China-based Keymed and nabs $180M

4 months ago

Lilly ventures into pulmonary fibrosis with startup Mediar

4 months ago

After lackluster 2024, biopharma industry prays stalled M&A will finally move into gear

4 months ago

Versant unveils Light Horse with $62M and a partnership with Novartis

4 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

4 months ago

Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partners

4 months ago

H1 buys General Catalyst-backed Ribbon Health

4 months ago

Revance weighs competing buyout offer amid push from original bidder

4 months ago

Transcarent buys health navigation incumbent Accolade for $621M

4 months ago

Roche's Chugai partners with Swiss ADC biotech Araris

4 months ago

Novo expands pact with Flagship's Valo to include obesity, diabetes for $190M near-term

4 months ago

Sanofi partners with Alloy Therapeutics to make new CNS drug

4 months ago

BWX Technologies to buy Canadian isotope maker for $525M

4 months ago

Pfizer extends AI drug discovery pact with PostEra, adding ADCs to deal

4 months ago

XyloCor raises $67.5M Series B, updates pivotal gene therapy trial plans

4 months ago

Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio

4 months ago

Vertex signs in vivo gene editing delivery pact for sickle cell and thalassemia as it looks beyond Casgevy

4 months ago

Ken Song's Candid licenses a T cell engager from WuXi Bio

4 months ago

Exclusive: Highlander Health, co-founded by ex-Verily execs, makes first acquisition

4 months ago

Teoxane issues competing buyout bid for Revance and its Botox rival

4 months ago

First page Previous page 3 4 567 8 9 Next page Last page